Fengler Justin
Known title: See RemarksCIK: 0002149552
Associated companies
Transaction History
| GDRX | ▲ Buy | Option Exercise | 2,335 | — | 9/15/2026 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 752 | — | 9/15/2026 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 330 | $1K | 9/15/2026 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 1,024 | $4K | 9/15/2026 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 10,149 | — | 8/15/2026 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 4,575 | $17K | 8/15/2026 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 6,423 | — | 8/15/2026 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 2,817 | $11K | 8/15/2026 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 2,803 | $10K | 8/15/2026 | View on chart |
| GDRX | ▼ Sell | Tax Withholding | 11,212 | $42K | 8/15/2026 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 6,392 | — | 8/15/2026 | View on chart |
| GDRX | ▲ Buy | Option Exercise | 25,568 | — | 8/15/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People
GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.